Vitreous substitutes and tamponades - A review of types, applications, and future directions.
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
01 Aug 2024
01 Aug 2024
Historique:
received:
02
09
2023
accepted:
27
03
2024
medline:
30
7
2024
pubmed:
30
7
2024
entrez:
30
7
2024
Statut:
ppublish
Résumé
Vitreous substitutes and tamponades occupy the vitreous cavity following vitrectomy in the management of various conditions such as retinal detachment, macular hole, and diabetic retinopathy. Such replacements can be for the short term (gases such as sulfur hexafluoride (SF6) and perfluoropropane (C3F8) or long term (such as silicone oils). Certain substitutes such as perfluorocarbon liquids are used only transiently during surgery as "a third hand" or rarely till a few days post surgery. Hydrogels and hyaluronan derivatives are among the newer vitreous substitutes that are showing promise for the future, albeit still under investigation. still being investigated for use as vitreous substitutes. These materials have properties similar to the natural vitreous and may offer advantages such as improved biocompatibility and biodegradability. Although vitreous substitutes are valuable tools in treating vitreoretinal conditions, they carry risks and potential complications such as cataract formation, glaucoma, and inflammation. The current communication extensively reviews the available literature on vitreous tamponades. It details the composition and properties of various vitreous substitutes and tamponades available for the clinician, highlighting the techniques of usage, indications, and limitations.
Identifiants
pubmed: 39078953
doi: 10.4103/IJO.IJO_2417_23
pii: 02223307-202472080-00006
doi:
Substances chimiques
Biocompatible Materials
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1102-1111Informations de copyright
Copyright © 2024 Copyright: © 2024 Indian Journal of Ophthalmology.
Références
Bishop PN. Structural macromolecules and supramolecular organization of the vitreous gel. Prog Retin Eye Res 2000;19:323–44.
Bos KJ, Holmes DF, Kadler KE, McLeod D, Morris NP, Bishop PN. Axial structure of the heterotypic collagen fibrils of vitreous humor and cartilage. J Mol Biol 2001;306:1011–22.
Nickerson CS, Park J, Kornfield JA, Karageozian H. Rheological properties of the vitreous and the role of hyaluronic acid. J Biomech 2008;41:1840–6.
Alovisi C, Panico C, Sanctis U de, Eandi CM. Vitreous substitutes: Old and new materials in vitreoretinal surgery. J Ophthalmol 2017;2017:1–6. doi: 10.1155/2017/3172138.
Grus FH, Joachim SC, Pfeiffer N. Proteomics in ocular fluids. Proteomics Clin Appl 2007;1:876–88.
Yadav I, Purohit SD, Singh H, Bhushan S, Yadav MK, Velpandian T, et al. Vitreous substitutes: An overview of the properties, importance, and development. J Biomed Mater Res B Appl Biomater 2021;109:1156–76.
Kleinberg TT, Tzekov RT, Stein L, Ravi N, Kaushal S. Vitreous substitutes: A comprehensive review. Surv Ophthalmol 2011;56:300–23.
Vaziri K, Schwartz SG, Kishor KS, Flynn HW Jr. Tamponade in the surgical management of retinal detachment. Clin Ophthalmol 2016;10:471–6.
Gonin J. The treatment of detached retina by searing the retinal tears. Arch Ophthalmol 1930;4:621–5.
Ishikawa K, Hisatomi T, Sakamoto T. Special adjuncts to treatment. In: Schachat PA, editor. Ryan’s RETINA. Vol 3, Part 1. Elsevier; 2018. p. 2092–142.
de Juan E, McCuen B, Tiedeman J. Intraocular tamponade and surface tension. Surv Ophthalmol 1985;30:47–51.
Fawcett IM, Williams RL, Wong D. Contact angles of substances used for internal tamponade in retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 1994;232:438–44.
Kreissig I. A Practical Guide to Minimal Surgery for Retinal Detachment. Vol 2. New York: Thieme Stuttgart; 2000. p. 110–270.
Pak KY, Lee SJ, Kwon HJ, Park SW, Byon IS, Lee JE. Exclusive use of air as gas tamponade in rhegmatogenous retinal detachment. J Ophthalmol 2017;2017:1341948. doi: 10.1155/2017/1341948.
Modi YS, Epstein A, Flynn HW, Shi W, Smiddy WE. Outcomes and complications of pneumatic retinopexy over a 12-year period. Ophthalmic Surg Lasers Imaging Retina 2014;45:132–7.
Kim SS, Smiddy WE, Feuer WJ, Shi W. Outcomes of sulfur hexafluoride (SF6) versus perfluoropropane (C3F8) gas tamponade for macular hole surgery. Retina 2008;28:1408–15.
McDonald HR, Schatz H, Johnson RN. Treatment of retinal detachment associated with optic pits. Int Ophthalmol Clin 1992;32:35–42.
Jang JH, Kim YC, Kim KS. The efficacy of fluid-gas exchange for the treatment of postvitrectomy retinal detachment. Korean J Ophthalmol 2009;23:253–8.
Lindtjørn B, Krohn J, Haugstad M, Stene-Johansen I, Austeng D, Basit S, et al. Air versus sulfur hexafluoride gas tamponade for small and medium-sized macular holes: A randomized noninferiority trial. Ophthalmol Retina 2022;6:828–34.
Chen YY, Yang CM. Intravitreal gas injection for early persistent macular hole after primary pars plana vitrectomy. BMC Ophthalmol 2022;22:369. doi: 10.1186/s12886-022-02599-1.
Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, et al. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Am J Ophthalmol 2014;157:1250–7.
Thompson JT. Kinetics of intraocular gases. Disappearance of air, sulfur hexafluoride, and perfluoropropane after pars plana vitrectomy. Arch Ophthalmol 1989;107:687–91.
Mateo-Montoya A, de Smet MD. Air as tamponade for retinal detachments. Eur J Ophthalmol 2014;24:242–6.
Hilton GF, Grizzard WS. Pneumatic retinopexy. A two-step outpatient operation without conjunctival incision. Ophthalmology 1986;93:626–41.
Alberti M, la Cour M. Face-down positioning versus non-supine positioning in macular hole surgery. Br J Ophthalmol 2015;99:236–9.
Kanclerz P, Grzybowski A. Complications Associated with the Use of Expandable Gases in Vitrectomy. J Ophthalmol 2018;2018:8606494. doi: 10.1155/2018/8606494.
Houston S, Graf J, Sharkey J. Commercial air travel after intraocular gas injection. Aviat Space Environ Med 2012;83:809–10.
Fromow-Guerra J, Solís-Vivanco A, Velez-Montoya R, Perez-Reguera A, Quiroz-Mercado H, Meza-de Regil A, et al. The effect of altitude on intraocular pressure in vitrectomized eyes with sulfur hexafluoride tamponade by the Friedenwald method: Rabbit animal model. BioMed Res Int 2016;2016:7326160. doi: 10.1155/2016/7326160.
Fang IM, Huang JS. Central retinal artery occlusion caused by expansion of intraocular gas at high altitude. Am J Ophthalmol 2002;134:603–5.
Fouad AN, Eissa IM, Nassar GA, Leila M, Fathy AM. Effect of pneumatic vitreolysis in management of patients with symptomatic focal vitreomacular traction. Int J Retina Vitr 2022;8:22. doi: 10.1186/s40942-022-00376-2.
Chan CK, Mein CE, Crosson JN. Pneumatic vitreolysis for management of symptomatic focal vitreomacular traction. J Ophthalmic Vis Res 2017;12:419–23.
Chan CK, Mein CE, Glassman AR, Beaulieu WT, Calhoun CT, Jaffe GJ, et al. Pneumatic vitreolysis with perfluoropropane for vitreomacular traction with and without macular hole: DRCR retina network protocols AG and AH. Ophthalmology 2021;128:1592–603.
Armaly MF. Ocular tolerance to silicones. I. Replacement of aqueous and vitreous by silicone fluids. Arch Ophthalmol 1962;68:390–5.
Cibis PA, Becker B, Okun E, Canaan S. The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol 1962;68:590–9.
Soós J, Resch MD, Berkó S, Kovács A, Katona G, Facskó A, et al. Comparison of hydrophilic ophthalmic media on silicone oil emulsification. PLoS One 2020;15:e0235067. doi: 10.1371/journal.pone. 0235067.
Scott IU, Flynn HW, Murray TG, Smiddy WE, Davis JL, Feuer WJ. Outcomes of complex retinal detachment repair using 1000- vs 5000-centistoke silicone oil. Arch Ophthalmol 2005;123:473–8.
Gabel VP, Kampik A, Gabel C, Spiegel D. Silicone oil with high specific gravity for intraocular use. Br J Ophthalmol 1987;71:262–7.
McCuen BW, Azen SP, Stern W, Lai MY, Lean JS, Linton KL, et al. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 3. Retina 1993;13:279–84.
Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: Results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol 1992;110:770–9.
Rush RB, Del Valle Penella A, Reinauer RM, Rush SW, Bastar PG. Silicone oil versus perfluoropropane gas tamponade during vitrectomy for tractional retinal detachment or fibrous proliferation: A randomized clinical trial. Retina 2021;41:1407–15.
Heimann K, Dahl B, Dimopoulos S, Lemmen KD. Pars plana vitrectomy and silicone oil injection in proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1989;227:152–6.
McLeod D. Microsurgical management of neovascularisation secondary to posterior segment ischaemia. Eye (Lond) 1991;5:252–9.
Castellarin A, Grigorian R, Bhagat N, Del Priore L, Zarbin MA. Vitrectomy with silicone oil infusion in severe diabetic retinopathy. Br J Ophthalmol 2003;87:318–21.
McCuen BW, Rinkoff JS. Silicone oil for progressive anterior ocular neovascularization after failed diabetic vitrectomy. Arch Ophthalmol 1989;107:677–82.
Girard P, Mimoun G, Karpouzas I, Montefiore G. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 1994;14:417–24.
Nashed A, Saikia P, Herrmann WA, Gabel VP, Helbig H, Hillenkamp J. The outcome of early surgical repair with vitrectomy and silicone oil in open-globe injuries with retinal detachment. Am J Ophthalmol 2011;151:522–8.
Zhang C, Xiao R, Wang A, Zhailicone oil–filled foldable capsular vitreous body versus silicone oil endotamponade for treatment of no light perception after severe ocular trauma. Retina 2022;42:553–560.
Dave VP, Joseph J, Jayabhasker P, Pappuru RR, Pathengay A, Das T. Does ophthalmic-grade silicone oil possess antimicrobial properties? J Ophthalmic Inflamm Infect 2019;9:20.
Mete M, Parolini B, Maggio E, Pertile G. 1000 cSt silicone oil vs heavy silicone oil as intraocular tamponade in retinal detachment associated to myopic macular hole. Graefes Arch Clin Exp Ophthalmol 2011;249:821–6.
Stefánsson E, Anderson MM, Landers MB, Tiedeman JS, McCuen BW. Refractive changes from use of silicone oil in vitreous surgery. Retina 1988;8:20–3.
Wei Y, Li Y, Chen F. Vitrectomy treatment of retinal detachments related to choroidal coloboma involving the disk. Retina 2014;34:1091–5.
Kapur R, Birnbaum AD, Goldstein DA, Tessler HH, Shapiro MJ, Ulanski LJ, et al. Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection. Retina 2010;30:140–5.
Heimann H, Stappler T, Wong D. Heavy tamponade 1: A review of indications, use, and complications. Eye (Lond) 2008;22:1342–59.
Prazeres J, Magalhães O, Lucatto LFA, Navarro RM, Moraes NS, Farah ME, et al. Heavy silicone oil as a long-term endotamponade agent for complicated retinal detachments. BioMed Res Int 2014;2014:136031. doi: 10.1155/2014/136031.
Morescalchi F, Costagliola C, Duse S, Gambicorti E, Parolini B, Arcidiacono B, et al. Heavy silicone oil and intraocular inflammation. BioMed Res Int 2014;2014:574825. doi: 10.1155/2014/574825.
Wong D, Van Meurs JC, Stappler T, Groenewald C, Pearce IA, McGalliard JN, et al. A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 2005;89:662–5.
Abu-Yaghi NE, Abu Gharbieh YA, Al-Amer AM, AlRyalat SAS, Nawaiseh MB, Darweesh MJ, et al. Characteristics, fates and complications of long-term silicone oil tamponade after pars plana vitrectomy. BMC Ophthalmol 2020;20:336. doi: 10.1186/s12886-020-01608-5.
Beekhuis WH, van Rij G, Zivojnović R. Silicone oil keratopathy: Indications for keratoplasty. Br J Ophthalmol 1985;69:247–53.
Franks WA, Leaver PK. Removal of silicone oil--rewards and penalties. Eye (Lond) 1991;5:333–7.
Ichhpujani P, Jindal A, Jay Katz L. Silicone oil induced glaucoma: A review. Graefes Arch Clin Exp Ophthalmol 2009;247:1585–93.
Kumar H, Talwar D, Thulasidas M, Taneja S. A new mechanism of silicone oil-induced glaucoma and its management. Case Rep Ophthalmol Med 2022;2022:2343139. doi: 10.1155/2022/2343139.
Cazabon S, Groenewald C, Pearce IA, Wong D. Visual loss following removal of intraocular silicone oil. Br J Ophthalmol 2005;89:799–802.
Roca JA, Wu L, Berrocal M, Rodriguez F, Alezzandrini A, Alvira G, et al. Un-explained visual loss following silicone oil removal: Results of the Pan American Collaborative Retina Study (PACORES) Group. Int J Retina Vitr 2017;3:26.
Lee JY, Kim JY, Lee SY, Jeong JH, Lee EK. Foveal microvascular structures in eyes with silicone oil tamponade for rhegmatogenous retinal detachment: A swept-source optical coherence tomography angiography study. Sci Rep 2020;10:2555.
Kiilgaard JF, Milea D, Løgager V, la Cour M. Cerebral migration of intraocular silicone oil: An MRI study. Acta Ophthalmol (Copenh) 2011 Sep; 89:522–5.
Chang S. Low viscosity liquid fluorochemicals in vitreous surgery. Am J Ophthalmol 1987;103:38–43.
Bourke RD, Simpson RN, Cooling RJ, Sparrow JR. The stability of perfluoro-N-octane during vitreoretinal procedures. Arch Ophthalmol 1996;114:537–44.
Sparrow JR, Matthews GP, Iwamoto T, Ross R, Gershbein A, Chang S. Retinal tolerance to intravitreal perfluoroethylcyclohexane liquid in the rabbit. Retina 1993;13:56–62.
Chou HD, Teh WM, Wu WC, Hwang YS, Chen KJ, Lai CC. Internal limiting membrane peeling and reposition (PAIR) for myopic foveoschisis. Retina 2023;43:2134–8.
Schulman JA, Peyman GA, Blinder KJ, Alturki WA, Desai UR, Nelson NC. Management of giant retinal tears with perfluoroperhydrophenanthrene (Vitreon). Jpn J Ophthalmol 1993;37:70–7.
Glaser BM, Carter JB, Kuppermann BD, Michels RG. Perfluoro-octane in the treatment of giant retinal tears with proliferative vitreoretinopathy. Ophthalmology 1991;98:1613–21.
Yu Q, Liu K, Su L, Xia X, Xu X. Perfluorocarbon Liquid: Its Application in Vitreoretinal Surgery and Related Ocular Inflammation. BioMed Res Int 2014;2014:250323. doi: 10.1155/2014/250323.
Movshovich A, Berrocal M, Chang S. The protective properties of liquid perfluorocarbons in phacofragmentation of dislocated lenses. Retina 1994;14:457–62.
Imamura Y, Minami M, Ueki M, Satoh B, Ikeda T. Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy. Br J Ophthalmol 2003;87:563–6.
Witkin AJ, Hsu J. Surgical repair of macular fold after vitrectomy for bullous rhegmatogenous retinal detachment. Retina 2012;32:1666–9.
Chou HD, Liu L, Wang CT, Chen KJ, Wu WC, Hwang YS, et al. Single-layer inverted internal limiting membrane flap versus conventional peel for small- or medium-sized full-thickness macular holes. Am J Ophthalmol 2022;235:111–9.
Lyu J, Xia F, Zhao P. Intraoperative perfluorocarbon liquid tamponade technique for treatment of extensive retinal detachment secondary to a myopic macular hole. Retina 2023;43:698–704.
Desai UR, Peyman GA, Chen CJ, Nelson NC, Alturki WA, Blinder KJ, et al. Use of Perfluoroperhydrophenanthrene in the Management of Suprachoroidal Hemorrhages. Ophthalmology 1992;99:1542–7.
Babu N, Kumar J, Kohli P, Ramasamy K. Perfluoro-n-octane-assisted mega Weiss-ring technique for posterior vitreous detachment induction in retinal detachment. Indian J Ophthalmol 2019;67:1463.
Ung C, Laíns I, Papakostas TD, Rahmani S, Miller JB. Perfluorocarbon liquid-assisted intraocular foreign body removal. Clin Ophthalmol 2018;12:1099–104.
Shukla D, Dhawan A, Kalliath J. Medium-term perfluoro-n-octane as rescue post-operative tamponade for very complex retinal detachments. Retina 2023;43:905–12.
Januschowski K, Irigoyen C, Pastor JC, Srivastava GK, Romano MR, Heimann H, et al. Retinal toxicity of medical devices used during vitreoretinal surgery: A critical overview. Ophthalmologica 2018;240:236–43.
Batman C, Cekic O. Effects of the long-term use of perfluoroperhydrophenanthrene on the retina. Ophthalmic Surg Lasers 1998;29:144–6.
Baino F. Towards an ideal biomaterial for vitreous replacement: Historical overview and future trends. Acta Biomater 2011;7:921–35.
Tobalem SJ, Weinberger A, Kropp M, Malcles A, Jonescu-Cuypers C, Souteyrand G, et al. Chorioretinal Toxicity of Perfluorooctane (Ala Octa): Results from 48 surgical procedures in Geneva. Am J Ophthalmol 2020;218:28–39.
Wagenfeld L, Zeitz O, Skevas C, Richard G. Long-lasting endotamponades in vitreoretinal surgery. Ophthalmologica 2010;224:291–300.
Kobuch K, Menz IH, Hoerauf H, Dresp JH, Gabel VP. New substances for intraocular tamponades: Perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 2001;239:635–42.
Zenoni S, Romano MR, Palmieri S, Comi N, Fiorentini E, Fontana P. Ocular tolerance and efficacy of short-term tamponade with double filling of polydimethyloxane and perfluoro-n-octane. Clin Ophthalmol 2011;5:443–9.
Zanzottera EC, Marchese A, Bandello F, Coppola M. Intraocular perfluorodecalin and silicone oil tamponade (double filling) in the management of complicated retinal detachment: Functional and anatomical outcomes using small-gauge surgery. Graefes Arch Clin Exp Ophthalmol 2022;260:1105–12.
Kramer KK, Thomassen T, Evaul J. Intraocular irrigating solutions: A clinical study of BSS plus and dextrose bicarbonate lactated Ringer’s solution. Ann Ophthalmol 1991;23:101–5.
de Bustros S, Glaser BM, Johnson MA. Thrombin infusion for the control of intraocular bleeding during vitreous surgery. Arch Ophthalmol 1985;103:837–9.
Li M, Tang Y, Li S, Zhang Z, Guan L, Li J, et al. Foldable capsular vitreous body implantation for complicated retinal detachment caused by severe ocular trauma. Retina 2022;42:1512.
Kopeček J. Hydrogel biomaterials: A smart future? Biomaterials 2007;28:5185–92.
Nishitsuka K, Kashiwagi Y, Tojo N, Kanno C, Takahashi Y, Yamamoto T, et al. Hyaluronan production regulation from porcine hyalocyte cell line by cytokines. Exp Eye Res 2007;85:539–45.
Chaterji S, Kwon IK, Park K. Smart Polymeric Gels: Redefining the Limits of Biomedical Devices. Prog Polym Sci 2007;32:1083–122.
Donati S, Caprani SM, Airaghi G, Vinciguerra R, Bartalena L, Testa F, et al. Vitreous substitutes: The present and the future. BioMed Res Int 2014;2014:351804. doi: 10.1155/2014/351804.
Cai P, Chen X. Hydrogels for artificial vitreous: From prolonged substitution to elicited regeneration. ACS Mater Lett 2019;1:285–9. doi: 10.1021/acsmaterialslett. 9b00145.
Sommer F, Kobuch K, Brandl F, Wild B, Framme C, Weiser B, et al. Ascorbic acid modulates proliferation and extracellular matrix accumulation of hyalocytes. Tissue Eng 2007;13:1281–9.